Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Rituximab × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 77 Lymphoma 48 Lymphoma, Non-Hodgkin 47 Lymphoma, Mantle-Cell 47 Lymphoma, Follicular 47 Lymphoma, B-Cell, Marginal Zone 41 Leukemia, Lymphocytic, Chronic, B-Cell 40 Lymphoma, B-Cell 28 Burkitt Lymphoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Waldenstrom Macroglobulinemia 17 Recurrence 17 Neoplasms 12 Leukemia 12 Leukemia, Hairy Cell 8 Hodgkin Disease 8 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm, Residual 4 Lymphoproliferative Disorders 4 Hematologic Diseases 4 Dendritic Cell Sarcoma, Interdigitating 4 Lymphoma, AIDS-Related 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Biphenotypic, Acute 3 Blast Crisis 3

Interventions

pembrolizumab 49 Cisplatin 38 Radiotherapy 24 Cetuximab 22 Carboplatin 20 Nivolumab 15 Paclitaxel 14 Docetaxel 14 Surveys and Questionnaires 11 Fluorouracil 11 Drug Therapy 10 Blood Specimen Collection 10 Radiotherapy, Intensity-Modulated 8 tislelizumab 7 atezolizumab 6 Radiation 6 Standard of Care 5 Afatinib 5 cemiplimab 4 Chemoradiotherapy 4 toripalimab 3 palbociclib 3 dostarlimab 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Fulvestrant 3 Erlotinib Hydrochloride 3 Equipment and Supplies 3 Capecitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡